Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factors Affecting Response to Neoadjuvant Chemotherapy in Cervical Carcinoma
NCT05384366Phase 3Completed
- Sponsor
- Banaras Hindu University
- Start
- Aug 2020
- Primary completion
- Mar 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, carboplatin in Cervical Cancer (CC), sponsored by Banaras Hindu University. Started Aug 2020; status: completed.
02
Drugs
paclitaxelcarboplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT05384366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05384366.